GIP concentrations were also increased during the latter stages of the trial; though GIP's contribution to the observed glucose-lowering was likely minor since endogenous GIP has little to no effect on postprandial glucoregulation in T2D (36). The gene discussed is GIP; the disease is type 2 diabetes mellitus.